SCOPUS 정보 검색 플랫폼

Regulatory Toxicology and Pharmacology

Volumn 35, Issue 2 I, 2002, Pages 266-272

Testing therapeutic potency of anticancer drugs in animal studies: A commentary

(3) Den Otter, Willem a,b,c Steerenberg, Peter A a,b Van der Laan, Jan Willem a

a MEDICINES EVALUATION BOARD (Netherlands)

b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT (Netherlands)

c UTRECHT UNIVERSITY (Netherlands)

Author keywords

Antineoplastic agents; Drug approval; Drug evaluation; Drug evaluation standards; Drug screening; Drug screening assays antitumor

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOSTATIC AGENT; CYTOTOXIC AGENT;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG APPROVAL; DRUG DETERMINATION; DRUG POTENCY; DRUG SCREENING; NETHERLANDS; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RODENT; ANIMAL; DISEASE MODEL; ECONOMICS; ETHICS; EXPERIMENTAL NEOPLASM; LEGAL ASPECT; METHODOLOGY; MOUSE; RAT; REVIEW; STANDARD;

ANIMALIA; RODENTIA;

ANIMALS; ANTINEOPLASTIC AGENTS; DISEASE MODELS, ANIMAL; DRUG APPROVAL; DRUG SCREENING ASSAYS, ANTITUMOR; MICE; NEOPLASMS, EXPERIMENTAL; NETHERLANDS; RATS; RESEARCH DESIGN;

EID: 0036081829 PISSN: 02732300 EISSN: None Source Type: Journal
DOI: 10.1006/rtph.2001.1522 Document Type: Article

Times cited : (10)

References (12)

1
- 0025690152
- Azaserine-induced pancreatic carcinogenesis in rats: Promotion by a diet rich in saturated fat and inhibition by a standard laboratory chow
- (1990) Cancer Lett. , vol.55 , pp. 239-248
- Appel, M.J.¹ Van Garderen-Hoetmer, A.² Woutersen, R.A.³

2
- 0017079968
- Regression of established tumors and induction of tumor immunity by intratumor chemotherapy
- (1976) J. Natl. Cancer Inst. , vol.56 , pp. 829-832
- Bast R.C., Jr.¹ Segerling, M.² Ohanian, S.H.³ Greene, S.L.⁴ Zbar, B.⁵ Rapp, H.J.⁶ Borsos, T.⁷

3
- 0001923783
- Cytotoxic alpha amino acids and peptides
- (1953) Annu. Rep. Br. Empire Cancer Campaign , vol.33 , pp. 6-7
- Bergel, F.¹ Stock, J.A.²

4
- 85031463992
- Commission Directive (91/507/EEC) of 19 July 1991 modifying the Annex to Council Directive 75/318/EEC on the approximation of the laws of member states relating to analytical, pharmacotoxicological and clinical standards and protocols in respect to the testing of medicinal products. Official J. Eur. Commun. No. L270/32 of 26.9.91

5
- 14444267319
- Regulatory considerations for preclinical development of anticancer drugs
- (1998) Cancer Chemother. Pharmacol. , vol.41 , pp. 173-185
- DeGeorge, J.J.¹ Ahn, C.-H.² Andrews, P.A.³ Brower, M.E.⁴ Giorgio, D.W.⁵ Goheer, M.A.⁶ Lee-Ham, D.Y.⁷ McGuinn, W.D.⁸ Schmidt, W.⁹ Sun, C.J.¹⁰ Tripathi, S.C.¹¹

6
- 0020025808
- Staging, growth properties and metastatic behaviour of a transplantable murine T-cell lymphoma
- (1982) Int. J. Tissue React. , vol.4 , pp. 15-25
- Dullens, H.F.J.¹ Hilgers, J.² Spit, B.J.³ De Heer, E.⁴ De Weger, R.A.⁵ Van Basten, C.D.H.⁶ Den Otter, W.⁷

7
- 0021961160
- EORTC guidelines for phase I trials with single agents in adults
- (1985) Eur. J. Cancer Clin. Oncol. , vol.21 , pp. 1005-1007

8
- 0005932350
- 22 July 1998, CPMP/SWP/997/96
- (1998) Note for Guidance on the Pre-clinical Evaluation of Anticancer Medicinal Products

9
- 37049160509
- Aryl-2-halogenoalkylamines. XII. Some carboxylic derivatives of NN-Di-2-chloroethylaniline
- (1953) J. Chem. Soc. , vol.3 , pp. 2386-2392
- Everett, J.L.¹ Roberts, J.J.² Ross, W.C.J.³

10
- 0001286133
- Myleran in chronic myeloid leukaemia: Chemical constitution and biological action
- (1953) Lancet , vol.1 , pp. 207-208
- Haddow, A.¹ Timmis, G.M.²

11
- 0021154170
- Evaluation of various cytostatic drugs as local immunotherapeutic agents
- (1984) Invest. New Drugs , vol.2 , pp. 221-225
- Scheper, R.J.¹ Vos, A.² De Groot, J.³ Boerrigter, G.H.⁴

12
- 0019407999
- Adoptive immunity to the guinea pig line 10 hepatoma and the nature of in vitro lymphoid-tumor cell interactions
- (1981) Cancer Res. , vol.41 , pp. 3499-3506
- Shu, S.¹ Steerenberg, P.A.² Hunter, J.T.³ Evans, C.H.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.